Methadone is substantially less effective than morphine in modifying locomotor and brain Fos responses to subsequent methadone challenge in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 6, 2009, Pages 1032-1039

  Taracha, Ewa ^a   Chrapusta, Stanisław J ^b   Lehner, Małgorzata ^a   Skórzewska, Anna ^a   Płaźnik, Adam ^a,c  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cortex; Hippocampus; Methadone; Morphine; Striatum; Substitution therapy

Indexed keywords

METHADONE; MORPHINE SULFATE; OPIATE; PROTEIN FOS; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; DRUG MEGADOSE; DRUG SENSITIZATION; EXPERIMENTAL MODEL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; LOW DRUG DOSE; MALE; NERVE CELL PLASTICITY; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; RAT; SOMATOSENSORY CORTEX; SPRAGUE DAWLEY RAT; THALAMUS;

ANIMALS; BRAIN CHEMISTRY; MALE; METHADONE; MORPHINE; MOTOR ACTIVITY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67651095723     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.05.015     Document Type: Article

References (51)

1. Ammon-Treiber S., and Höllt V. Morphine-induced changes of gene expression in the brain. Addict Biol 10 (2005) 81-89
2. Babbini M., and Davis W.M. Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment. Br J Pharmacol 46 (1972) 213-224
3. Babbini M., Gaiardi M., and Bartoletti M. Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment. Neuropharmacology 14 (1975) 611-614
4. Badiani A., and Robinson T.E. Drug-induced neurobehavioral plasticity: role of environmental context. Behav Pharmacol 15 (2004) 327-339
5. Bartoletti M., Gaiardi M., Gebellini C., Bacchi A., and Babbini M. Cross-sensitization to the excitatory effect of morphine in post-dependent rats. Neuropharmacology 24 (1985) 889-893
6. Canales J.J. Adult neurogenesis and the memories of drug addiction. Eur Arch Psychiatry Clin Neurosci 257 (2007) 261-270
7. Celentano M., Caprioli D., Dipasquale P., Cardillo V., Nencini P., Gaetani S., et al. Drug context differently regulates cocaine versus heroin self-administration and cocaine- versus heroin-induced Fos mRNA expression in the rat. Psychopharmacology 204 (2009) 349-360
8. Curran E.J., Akil H., and Watson S.J. Psychomotor stimulant and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem Res 21 (1996) 1425-1435
9. De Vries T.J., Schoffelmeer A.N., Binnekade R., Mulder A.H., and Vanderschuren L.J. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur J Neurosci 10 (1998) 3565-3571
10. Donny E.C., Brasser S.M., Bigelow G.E., Stitzer M.L., and Walsh S.L. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction 100 (2005) 1496-1509
11. Everitt B.J., Dickinson A., and Robbins T.W. The neuropsychological basis of addictive behaviour. Brain Res Rev 36 (2001) 129-138
12. Fasano S., and Brambilla R. Cellular mechanisms of striatum-dependent behavioral plasticity and drug addiction. Curr Mol Med 2 (2002) 649-665
13. Garcia M.M., Brown H.E., and Harlan R.E. Alternations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Res 692 (1995) 23-40
14. Harlan R.E., and Garcia M.M. Drugs of abuse and immediate-early genes in the forebrain. Mol Neurobiol 16 (1998) 221-267
15. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29 (2006) 565-598
16. Johnson A., van der Meer M.A., and Redish A.D. Integrating hippocampus and striatum in decision making. Curr Opin Neurobiol 17 (2007) 692-697
17. Joyce E.M., and Iversen S.D. The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci Lett 14 (1979) 207-212
18. Kalinichev M., White D.A., and Holtzman S.G. Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization. Psychopharmacology 177 (2004) 61-67
19. Kilts C.D. Imaging the roles of the amygdala in drug addiction. Psychopharmacol Bull 35 (2001) 84-94
20. Kreek M.J. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci 909 (2000) 186-216
21. Kreek M.J., and Vocci F.J. History and current status of opioid maintenance treatments: blending conference session. J Subst Abuse Treat 23 (2002) 93-105
22. Langleben D.D., Ruparel K., Elman I., Busch-Winokur S., Pratiwadi R., Loughead J., et al. Acute effect of methadone maintenance dose on brain fMRI response to heroin-related cues. Am J Psychiatry 165 (2008) 390-394
23. Le Moal M., and Koob G.F. Drug addiction: pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol 17 (2007) 377-393
24. Leri F., Tremblay A., Sorge R.E., and Stewart J. Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacology 29 (2004) 1312-1320
25. Leri F., Sorge R.E., Cummins E., Woehrling D., Pfaus J.G., and Stewart J. High-dose methadone maintenance in rats: effects on cocaine self-administration and behavioral side effects. Neuropsychopharmacology 32 (2007) 2290-2300
26. Ling G.S., Umans J.G., and Inturrisi C.E. Methadone: radioimmunoassay and pharmacokinetics in the rat. J Pharmacol Exp Ther 217 (1981) 147-151
27. Mas-Nieto M., Pommier B., Tzavara E.T., Caneparo A., Da Nascimento S., Le Fur G., et al. Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction. Br J Pharmacol 132 (2001) 1809-1816
28. Mendez I.A., and Trujillo K.A. NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats. Psychopharmacology 196 (2008) 497-509
29. Milton A.L., Lee J.L., Butler V.J., Gardner R., and Everitt B.J. Intra-amygdala and systemic antagonism of NMDA receptors prevents the reconsolidation of drug-associated memory and impairs subsequently both novel and previously acquired drug-seeking behaviors. J Neurosci 28 (2008) 8230-8237
30. Nava F., Manzato E., and Lucchini A. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1089-1094
31. Nava F., Manzato E., Leonardi Z., and Lucchini A. Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1867-1872
32. Nestler E.J. Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem 78 (2002) 637-647
33. Obernier J.A., and Baldwin R.L. Establishing an appropriate period of acclimatization following transportation of laboratory animals. ILAR J 47 (2006) 364-369
34. Paolone G., Conversi D., Caprioli D., Del Bianco P., Nencini P., Cabib S., et al. Modulatory effect of environmental context and drug history on heroin-induced psychomotor activity and Fos protein expression in the rat brain. Neuropsychopharmacology 32 (2007) 2611-2623
35. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, San Diego
36. Pollock J., and Kornetsky C. Reexpression of morphine oral stereotypy six months after last morphine sensitizing dose. Pharmacol Biochem Behav 53 (1996) 67-71
37. Pontieri F.E., Calo L., Di Grezia R., Orzi F., and Passarelli F. Functional correlates of heroin sensitization in the rat brain. Eur J Pharmacol 335 (1997) 133-137
38. Robinson T.E., and Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 Suppl 1 (2004) 33-46
39. Samaha A.N., Li Y., and Robinson T.E. The rate of intravenous cocaine administration determines susceptibility to sensitization. J Neurosci 22 (2002) 3244-3250
40. Samaha A.N., Yau W.Y., Yang P., and Robinson T.E. Rapid delivery of nicotine promotes behavioral sensitization and alters its neurobiological impact. Biol Psychiatry 57 (2005) 351-360
41. Shi J., Zhao L.Y., Fanf Y.X., Chen Y., Tian J., Deng Y., et al. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol 79 (2008) 160-166
42. Steinbarth-Chmielewska K., Habrat B., and Baran-Furga H. Spontaneous reduction of methadone doses during substitution therapy. Abstracts of the 11th ESAR Conference, Meissen-Dresden, Germany, 3-6 May (2007) 10. http://www.easar.com/download/11thEASARConference_Abstracts.pdf http://www.easar.com/download/11thEASARConference_Abstracts.pdf
43. Stewart J. Conditioned and unconditioned drug effectsin relapse to opiate and stimulant drug self-administration. Prog Neuropsychopharmacol Biol Psychiatry 7 (1983) 591-597
44. Stewart J., and Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4 (1993) 289-312
45. Taracha E., Lehner M., Wisłowska-Stanek A., Zienowicz M., Maciejak P., Bidziński A., et al. Effects of methadone and morphine on c-Fos expression in the rat brain: similarities and differences. Pharmacol Rep 58 (2006) 120-124
46. Taracha E., Chrapusta S.J., Lehner M., Skórzewska A., Maciejak P., Szyndler J., et al. Morphine and methadone pre-exposures differently modify brain regional Fos protein expression and locomotor activity responses to morphine challenge in the rat. Drug Alcohol Depend 97 (2008) 21-32
47. Taracha, E., Mierzejewski, P., Lehner, M., Chrapusta, S.J., Skórzewska, A., Kała, M., et al., Stress-opioid interactions: a comparison of morphine and methadone. Pharmacol Rep 2009;61: in press.
48. Taracha E., Habrat B., Chmielewska K., and Baran-Furga H. Excretion profile in dependent patients in relation to route of administration and type of drug measured in urine with immunoassay. J Anal Toxicol 29 (2005) 19-21
49. Vanderschuren L.J., Tjon G.H., Nestby P., Mulder A.H., Schoffelmeer A.N., and De Vries T.J. Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of pretreatment regimen. Psychopharmacology 131 (1997) 115-122
50. Vezina P., Kalivas P.W., and Stewart J. Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist, DAGO, administered repeatedly to ventral tegmental area but not to the nucleus accumbens. Brain Res 417 (1987) 51-58
51. White N.M. Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91 (1996) 921-949